Moreover, IL-4Rα deficiency results in inhibition of bone marrow-derived fibroblast activation and markedly reduces the progression of renal fibrosis, highlighting the potential therapeutic implications of targeting IL-4Rα in fibrotic kidney diseases. The gene discussed is IL4R; the disease is renal fibrosis.